Never miss a story

Get subscribed to our newsletter


×
Tocilizumab improves hospital survival in critically ill Covid-19 patients admitted to the intensive care unit. Pinterest

A drug normally used in rheumatoid arthritis and cancer treatments — tocilizumab — improves hospital survival in critically ill Covid-19 patients admitted to the intensive care unit (ICU), say researchers.

The study, published in the journal The Lancet Rheumatology, included 630 patients who were admitted to the ICUs of 13 Hackensack Meridian Health hospitals in New Jersey.


Among other treatments, tocilizumab was considered for off-label usage for the patients whose respiratory symptoms were declining; many of whom were requiring mechanical ventilator support.

Follow NewsGram on LinkedIn to know what’s happening around the world.

In the observational study, 210 patients received tocilizumab, and the other 420 did not.

“Our work in treating this terrible virus, and learning more about it each day, continues to benefit thousands of patients as the pandemic continues,” said Robert C Garrett, CEO from the Hackensack Meridian Health in the US.


Tocilizumab is a monoclonal antibody, which binds and blocks the interleukin (IL)-6 receptor and helps damper the inflammatory response. Pinterest

Covid-19 has three phases: the early or viral phase (with fast viral replication), the pulmonary phase (marked by inflammation and pneumonia as the body tries to fight the virus in the lungs) and the inflammatory phase (in which excessive inflammation reaches and affects many organs and patients are often in the ICU).

As part of both the pulmonary and inflammatory phases, the immune system is “supercharged” and secretes in the blood numerous cytokines, particularly interleukin (IL)-6, which induces further inflammation.

Tocilizumab is a monoclonal antibody, which binds and blocks the interleukin (IL)-6 receptor and helps damper the inflammatory response.

Want to read more in Hindi? Checkout: कोरोना के दौर में ‘वर्क फ्रॉम होम’ वालों की भी कहानी सुनने लायक

The activity of tocilizumab was first shown in chimeric antigen receptor (CAR) T-cell therapy, where a similar phenomenon of overactive and growing T cells induce a “cytokine storm.”

This provided a rationale to try tocilizumab in Covid-19 patients.

The findings showed a statistically significant decrease in hospital-related deaths among the patients who received the tocilizumab.


There was roughly 36% decrease in hospital-related mortality among the ICU patients who received the drug, as compared with patients in the ICU who didn’t receive it. Pinterest

A roughly 36 per cent decrease in hospital-related mortality among the ICU patients who received the drug, as compared with patients in the ICU who didn’t receive it.

Also Read: I Feel Comedy can be Utilised for Positive Changes: Vir Das

Importantly, it appeared that higher levels of a blood test marker of inflammation, C-reactive protein, could predict which ICU patients might benefit most from the tocilizumab therapy, potentially allowing doctors to tailor therapy to those most in need.

“These real-time findings have helped to point us the way forward,” the study authors wrote.

Earlier this month, another study published in the International Journal of Infectious Diseases, found that patients experiencing severe Covid-19 symptoms had improved outcomes when administered an Interleukin-6 (IL6ri) inhibitor, sarilumab or tocilizumab. (IANS)


Popular

wikimedia commons

Tenali Raman, courtier to Krishnadevaraya (A portrait)


Tenali Ramakrishna, or Tenali Raman as he is more popularly known is Birbal's equivalent in South India. A court jester and a scholar exuding great wisdom, Tenali Raman was known as one of the greatest courtiers in King Krishnadevaraya's court.

Keep Reading Show less
Photo by Pixabay

Battle at Lanka as mentioned in the Ramayana

It must be noted that different religions and societies in Southeast Asia have alternative narratives of Ramayana, one of the greatest epic.

Here are some of the versions of Ramayana!

Keep Reading Show less
Virendra Singh Gosain, Hindustan Times

Hijras are a community of people who include eunuchs, intersex, and transgender people

When a baby is born in an Indian household-they invite hijra to shower the newborn with their blessings for their blessings confer fertility, prosperity, and long life on the child. But when that child grows up we teach them to avert their eyes when a group of hijras passes by, we pass on the behaviour of treating hijras as lesser humans to our children. Whenever a child raises a question related to gender identity or sexuality they are shushed down. We're taught to believe that anything "deviant" and outside of traditional cis-heteronormativity is something to be ashamed of. This mentality raises anxious, scared queer adults who're ashamed of their own identity, and adults who bully people for "queer behaviour".

Hijras are a community of people who include eunuchs, intersex, and transgender people. They worship the Hindu goddess of chastity and fertility, Bahuchara Mata. Most hijras, but not all, choose to undergo a castration ceremony known as "nirvana" in which they remove their male genitalia as an offering to their goddess. The whole community is vibrant with hundreds of people with hundreds of ways of expression, the true identity of a hijra is complex and unique to each individual. In India, hijras prefer to refer to themselves as Kinner/Kinnar as it means the mythological beings who excel at singing and dancing.

Keep reading... Show less